- 11-02-2025Background Infection with the COVID-19-causing pathogen SARS-CoV-2 is associated with disruption in the human gut microbiome. The gut microbiome enables…
- 26-08-2024Abstract Background Mixed M. tuberculosis (MTB) infection occurs when one is infected with more than one clonally distinct MTB strain.…
- 26-08-2024Introduction Susceptibility testing for pyrazinamide (PZA), a cornerstone anti-TB drug is not commonly done in Uganda because it is expensive…
- 26-08-2024Background: TB (Tuberculosis) is the second leading killer infectious disease after HIV (human immunodeficiency virus). Its incidence is worsened by…
- 26-08-2024Tuberculosis (TB) resistance to rifampicin, the most powerful drug leads to increase in mortality. Globally, half a million new patients…
- 26-08-2024Introduction: Resistance to antituberculosis drugs and adverse drug reactions remain the leading causes of tuberculosis therapeutic failure globally. Despite the…
- 26-08-2024Abstract Background The Global Laboratory Initiative (GLI) guidelines recommend repeat for GeneXpertMTB/RIF (XpertMTB/RIF) in patients with a low pretest probability…
- 26-08-2024Introduction: Performance of rapid molecular diagnostic test in detecting drug resistant Mycobacterium tuberculosis (MTB) is key in controlling the infection…
